interleukin
Founded 2021 · 7 employees on LinkedIn · 1 known investors
Interleukin operates a B2B platform for sourcing and procuring medical products and services, letting registered buyers discover accredited suppliers, request quotes, send purchase orders, and pay on terms in one system. It targets medical institution buyers and distributors/suppliers in the Philippines.
Also known as InterLeukin
Investors · 1
Company profile
researched Aug 2026InterLeukin operates a business-to-business online platform for sourcing and procuring medical products and services. Buyers register on the platform to discover accredited suppliers and brands, request quotes from multiple suppliers, manage purchase orders, and pay using several payment options and terms within a single system. The company also offers a strategic sourcing service in which its team maintains supplier and category listings and assists buyers with posting their requirements.
On the supply side, suppliers use the platform to promote products directly to buyers, build custom online product catalogs, participate in and bid on requests for quotation (RFQs) issued by medical institutions and purchasers, manage quotes from verified buyer institutions, handle orders and logistics, and receive payment. The company positions the platform around three entry paths: posting sourcing needs, creating or responding to an RFQ, and registering as a buyer. Supporting elements described on its site include a marketplace, a help center, articles and other resources, and featured brands and partners.
Business model
The platform intermediates between medical institution buyers and distributors/suppliers, hosting RFQs, quotes, purchase orders and payments; suppliers become accredited members to access RFQ flow from buyer institutions.
Traction
The company reports 1 million product units sold, more than 500 B2B users participating, more than 50,000 SKUs available for selection, and average transaction amounts of PHP 100,000 and up.
▸Full profile — market position, technology, go-to-market, geography
Market position
Describes itself as part of the Philippines' largest and most active network of B2B medical buyers and distributors/suppliers, addressing medical products and services that buyers report difficulty finding elsewhere.
Consolidates multi-supplier quote requests, purchase order management, logistics and payment on terms in one platform, combined with a team-assisted strategic sourcing option and supplier accreditation.
Technology
Web-based procurement platform covering supplier and product search, RFQ creation and bidding, quote management, purchase order handling, order and logistics management, online product catalogs, and payments with multiple options and terms.
Go-to-market
Self-service registration for buyers and suppliers, supplier accreditation, RFQ posting, explanatory videos and meeting scheduling, and promotion through featured brands and partners as well as LinkedIn, Facebook, Twitter and Instagram channels.
Medical institutions and purchasers that buy medical products and services, and the distributors and suppliers that serve them.
Geography
Focused on the Philippines, where the company describes itself as part of the country's B2B medical buyer and distributor/supplier network; buyers can source brands from multiple locations.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 8
primary sources listed
- interleukininterleukin.co · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does interleukin do?
- InterLeukin is a Philippine B2B platform where medical institutions source products and services from accredited suppliers.
- Who are interleukin's investors?
- interleukin's investors include Buko Ventures.